FIELD: biotechnologies.
SUBSTANCE: invention relates to biotechnology, virology and immunology. Disclosed are immunogenic compositions containing protein F RSV. Compositions contain polypeptides protein ecto domains F RSV in predominant or one desired shape and conformation.
EFFECT: proposed inventions can be used in medicine.
16 cl, 13 dwg, 22 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED SV F PROTEINS OF SV AND METHODS OF USING THEM | 2009 |
|
RU2531510C2 |
| ANTIGENIC POLYPEPTIDES BASED ON THE RESPIRATORY SYNCYTIAL VIRUS SEQUENCE | 2019 |
|
RU2807992C2 |
| NEW SOLUBLE AND STABILISED TRIMERIC FORM OF GP41 POLYPEPTIDES | 2004 |
|
RU2390525C2 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| STABILIZED F RSV PROTEINS AND THEIR USE | 2019 |
|
RU2795459C2 |
| HEMAGGLUTININ-CONTAINING CHIMERIC VIRUS-LIKE PARTICLES, SIMILAR TO PARTICLES OF FLU VIRUS | 2010 |
|
RU2569195C9 |
| RECOMBINANT IMMUNOTOXIN AIMED AT MESOTHELIN | 2012 |
|
RU2600067C2 |
| RESPIRATORY SYNCYTIAL VIRUS ANTIGENIC COMPOSITIONS AND METHODS | 2011 |
|
RU2609661C2 |
| PRODUCTION OF VIRUS-LIKE PARTICLES IN PLANTS | 2011 |
|
RU2655431C2 |
| TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF | 2013 |
|
RU2680581C2 |
